Idiopathic Parkinson Disease
📧 Sign up to get email alerts when something new happens for Idiopathic Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-09-09Clinical Trial Update: Prolactin, Inflammation, and Parkinson's Severity
An ongoing invitation-only trial from Çanakkale Onsekiz Mart University is examining the relationship between prolactin, inflammation, and P…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Infusion of Apomorphine: Long-term Safety Study [Phase 3]
This is a Phase 3 long-term safety study evaluating infusion of apomorphine in idiopathic Parkinson's disease. The trial is currently active…
-
CLINICAL_TRIALS research · 2019-10-29Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease [Phase 1, Phase 2]
A clinical trial update reports pharmacokinetics and pharmacodynamics data for IPX054 in subjects with idiopathic Parkinson's disease from P…
-
CLINICAL_TRIALS research · 2015-12-02Clinical Trial Update: Vascular Abnormalities in Idiopathic Parkinson's Disease
A clinical trial update focusing on vascular abnormalities in idiopathic Parkinson's disease; the current status is unknown.
-
CLINICAL_TRIALS research · 2010-02-19Clinical Trial Update: A Multi-Center, Observational Safety Registry of Subjects With Idiopathic Parkinson's Disease Previously Treated With Intraputaminal Infusion of Liatermin
This entry notes the completion of a multi-center observational safety registry evaluating Parkinson's disease patients who were previously …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2007-07-10Clinical Trial Update: The APOS System: Effects on Gait, Mobility and QOL in Patients With Parkinson's Disease [Phase 2]
This entry summarizes a Phase 2 clinical trial evaluating the APOS System's effects on gait, mobility and quality of life in patients with i…